Jeito Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Neurology
- Cardiology
- Endocrinology
- Infectious Diseases
- Immuno-Oncology
- Rare Diseases
- Ophthalmology
- Orthopedics
- Gastroenterology
- Hematology
- Fibrosis
- Dermatology
- Cancer
- Respiratory Diseases
Investment Size:
10,000,000 to 100,000,000 USD
Investor Details
Jeito Capital is a global leading investment company with a patient benefit-driven approach that finances and accelerates the development and growth of groundbreaking medical innovation. The firm manages €534 million under management and is based in Paris, with a presence in Europe and the United States. Jeito Capital supports and accompanies entrepreneurs through its multidisciplinary team of experts across the entire drug value chain, as well as through significant capital contributions to ensure the growth of companies. This approach contributes to the emergence of leaders in specific therapeutic areas and accelerates the commercialization of innovative treatments worldwide, particularly in Europe and the United States, for the benefit of patients.
Jeito Capital has built a solid and diverse portfolio of European biopharmaceutical companies, investing in diversified therapeutic areas such as immuno-oncology, ophthalmology, cardiology, severe respiratory diseases, fibrosis, and associated cancers. The firm's unique investment strategy provides significant capital and support in continuity to entrepreneurs and companies from clinical development to market access for breakthrough innovations. This strategy aims to build market leaders in their respective therapeutic areas with accelerated patient access globally, especially in Europe and the United States.
The team at Jeito Capital comprises professionals with over 20 years of experience across the entire value chain of the healthcare sector, from developing groundbreaking therapies to mastering IP strategy, achieving regulatory milestones, and bringing them to market. This integrated, multi-talented team enables Jeito Capital to empower and support entrepreneurs effectively, ensuring the growth and success of their portfolio companies in the competitive biopharmaceutical industry.
Requirements
- Focus on patient benefit-driven medical innovations
- Presence in Europe and the United States
- Diversified therapeutic areas including immuno-oncology, ophthalmology, cardiology, severe respiratory diseases, fibrosis, and associated cancers
- Experienced management teams with a proven track record in the healthcare sector
- Innovative treatments addressing high unmet medical needs
- Potential for accelerated commercialization and global market access
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Claim this Investor
Are you an official representative of Jeito Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim